Low Dose Naltrexone
This popular treatment for many ailments, and with regard to cancer has been shown to inhibit tumor growth and stimulate the endorphin system which supports immune function. Naltrexone specifically affects the Opioid Growth Factor (OGF) receptor by interfering with the binding of Opioid Growth Factor (OGF). OGF is responsible for regulating cell growth, wound repair, supports the immune system and has an anti-cancer function.
LDN blocks the OGF receptors for only a few hours before it is naturally excreted, resulting in a “rebound effect”, in which both the body’s production and utilization of OGF is greatly increased before LDN is gone. The elevated OGF produced can now assist in regulating cell growth and immunity. Benefits of the rebound effect only happen with low doses of Naltrexone.